why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat

Course: OpenNotes: Your Patients Can Read Your Notes. Now What?

CME Credits: 1.00

Released: 2023-01-17

Program Description
Hospital for Special Surgery
Catherine DesRoches discusses OpenNotes, the 21st Century CURES act implementation, and how those impact patients and clinicians.
About this Series
HSS Rheumatology Grand Rounds feature recorded sessions of HSS and other prominent guest faculty discussing timely topics that highlight the latest developments in the field of rheumatology including diagnostic and treatment advances.
References
Alpert, J. M., Morris, B. B., Thomson, M. D., et al. (2019). Patient access to clinical notes in oncology: A mixed method analysis of oncologists' attitudes and linguistic characteristics towards notes. Patient education and counseling, 102(10), 1917–1924.
Bell, S. K., Delbanco, T., Elmore, J. G., et al. (2020). Frequency and Types of Patient-Reported Errors in Electronic Health Record Ambulatory Care Notes. JAMA network open, 3(6), e205867.
Bruno, B., Steele, S., Carbone, J., et al. (2022). Informed or anxious: patient preferences for release of test results of increasing sensitivity on electronic patient portals. Health and technology, 12(1), 59–67.
Chimowitz, H., O'Neill, S., Leveille, S., et al. (2020). Sharing Psychotherapy Notes with Patients: Therapists' Attitudes and Experiences. Social work, 65(2), 159–168.
DesRoches, C. M., Leveille, S., Bell, S. K., et al. (2020). The Views and Experiences of Clinicians Sharing Medical Record Notes With Patients. JAMA network open, 3(3), e201753.
Dobscha, S. K., Kenyon, E. A., Pisciotta, M. K., et al. (2019). Impacts of a Web-Based Course on Mental Health Clinicians' Attitudes and Communication Behaviors Related to Use of OpenNotes. Psychiatric services (Washington, D.C.), 70(6), 474–479.
Lam, B. D., Bourgeois, F., DesRoches, C. M., et al. (2021). Attitudes, experiences, and safety behaviours of adolescents and young adults who read visit notes: Opportunities to engage patients early in their care. Future healthcare journal, 8(3), e585–e592.
Leonard, L. D., Himelhoch, B., Huynh, V., et al. (2022). Patient and clinician perceptions of the immediate release of electronic health information. American journal of surgery, 224(1 Pt A), 27–34.
P Goddu, A., O'Conor, K. J., Lanzkron, S., et al. (2018). Do Words Matter? Stigmatizing Language and the Transmission of Bias in the Medical Record. Journal of general internal medicine, 33(5), 685–691.
Rahimian, M., Warner, J. L., Jain, S. K., et al. (2019). Significant and Distinctive n-Grams in Oncology Notes: A Text-Mining Method to Analyze the Effect of OpenNotes on Clinical Documentation. JCO clinical cancer informatics, 3, 1–9.
Rahimian, M., Warner, J. L., Salmi, et al. (2021). Open notes sounds great, but will a provider's documentation change? An exploratory study of the effect of open notes on oncology documentation. JAMIA open, 4(3), ooab051.
Richards, S., Carlson, K., Matthias, T., & Birge, J. (2021). Perception versus reality: Does provider documentation behavior change when clinic notes are shared electronically with patients?. International journal of medical informatics, 145, 104304.
Salmi, L., Dong, Z. J., Yuh, B., Walker, J., & DesRoches, C. M. (2020). Open Notes in Oncology: Patient versus Oncology Clinician Views. Cancer cell, 38(6), 767–768.
Walker, J., Leveille, S., Bell, S., et al. (2019). OpenNotes After 7 Years: Patient Experiences With Ongoing Access to Their Clinicians' Outpatient Visit Notes. Journal of medical Internet research, 21(5), e13876.
Intended Audience
This activity is targeted to physicians and scientists working in the specialties of orthopedics, rheumatology, radiology, anesthesiology, pediatrics, physiatry, pathology, and neurology, including HSS alumni and current residents, fellows, and medical staff.
Commercial Support
This activity is not commercially supported.


Educational Objectives
HSS Continuing Education activities are intended to improve the quality of patient care and safety. At the conclusion of this course, the participant will be able to:
Summarize current research related to new pharmacologic therapies for various rheumatologic conditions including (but not limited to) systemic lupus erythematosus, inflammatory arthritis, crystalline arthritis (such as gout), scleroderma, myositis, vasculitis, and osteoarthritis.
Recognize the risk factors (clinical, genetic, environmental) associated with various rheumatic conditions including (but not limited to) systemic lupus erythematosus, inflammatory arthritis, crystalline arthritis (such as gout), scleroderma, myositis, vasculitis, and osteoarthritis.
Define the pathophysiology underlying various rheumatic conditions including (but not limited to) systemic lupus erythematosus, inflammatory arthritis, crystalline arthritis (such as gout), scleroderma, myositis, vasculitis, and osteoarthritis.


View Full Course